Skip to main content

Mexico Health Review 2019

Page 89

Patent expires

10 months

First market launch of the generic medication

0.4%

First “generic” sanitary registration

16 months

1.3%

TIMELINE FOR THE INTRODUCTION OF A GENERIC MEDICINE TO THE MARKET

GENERICS AFTER PATENT EXPIRATION

0

-10 -15 -20 -25 -30

12 months

• Generics

-28.6%

Market penetration

85

-5

-23.2%

Price variation*

21.4%

-20.6%

12.7%

6 months

2.5%

5

8.3%

• Patents

95 percent of medicines manufactured in Mexico are generics

24 months

*The baseline price is the cost of the patent medication one month after its release

COST DIFFERENCE BETWEEN PATENT AND GENERIC DRUGS IN MEXICO (percentage)

MAIN PHARMACEUTICAL EXPORT DESTINATIONS

51 Others

47

Infectious

Neurological

73

70 Pulmonary

39 Oncologic

0

55 Endocrinology

20

64 Cardiovascular disease

40

Diabetes

60

72

80

MEXICO’S PHARMACEUTICAL EXPORTS

73%

Retail medicines

10%

Wadding, gauze and bandage

9%

Antivenom and vaccines

6%

Pharmaceutical product and preparations

2%

Others

100

80

46.3% Other

60

6.7% Colombia 40

10.3% Panama 20

36.7% US 0

Mexico has 795 pharmaceutical businesses


Turn static files into dynamic content formats.

Create a flipbook
Mexico Health Review 2019 by Mexico Business Publishing - Issuu